Table 3 The gap analysis model: criteria considered, levels within the criteria, scores and applied weighting coefficients (Coef)

Diagnostic tools

2

1

0

−1

−2

4.17

/100

 1. Availability^a

 2. Prevention and control - Differentiation of infected from vaccinated (DIVA)

 3. Strategic reserve

 4. Capacity of production

 5. Market potential

 6. Affordable

 7. Quality/stability durability

 8. Sensitivity

 9. Specificity

 10. Reproducibility

 11. Simplicity/ease of use

 12. Speed

Vaccination tools

2

1

0

−1

−2

4.55

/100

 1. Commercial availability^a

 2. Monitoring for infection in a vaccinated population

 3. Strategic reserve

 4. Capacity of production

 5. Market potential

 6. Affordable

 7. Quality/stability

 8. Safety of vaccines

 9. Efficacy

 10. Immunity

 11. Convenience of use

Pharmaceutical tools

2

1

0

−1

−2

4.55

/100

 1. Availability^a

 2. Prevention and control

 3. Strategic reserve

 4. Capacity of production

 5. Market potential

 6. Cost

 7. Quality

 8. Safety animal

 9. Safety consumer/user concerns

 10. Safety environment

 11. Resistance

Total Score: